Stocks in news today, May 14: Bharti Airtel, Oil India, Tata Motors CV, Zydus Lifesciences, DLF, Crompton Greaves and more
Aditya B
Several stocks are likely to remain in focus on Thursday, May 14, following quarterly results, order wins, corporate updates, dividend actions, surveillance framework changes and sector-specific developments.
Among the positive earnings updates, Quality Power reported Q4 net profit of Rs 34 crore compared with Rs 19 crore year-on-year, while revenue rose to Rs 281 crore from Rs 108 crore. NLC India posted Q4 net profit of Rs 1,394 crore against Rs 482 crore YoY, with revenue rising to Rs 5,043 crore from Rs 3,836 crore. IKS reported net profit of Rs 206 crore against Rs 148 crore YoY, while revenue stood at Rs 858 crore compared with Rs 724 crore.
Oil India will also remain in focus after reporting Q4 net profit of Rs 2,424 crore compared with Rs 1,435 crore QoQ, while revenue rose to Rs 10,012 crore from Rs 9,111 crore. Tata Motors CV reported Q4 net profit of Rs 2,406 crore against Rs 561 crore YoY, with revenue rising to Rs 24,452 crore from Rs 20,404 crore. Bharti Hexacom posted Q4 net profit of Rs 446 crore against a loss of Rs 473 crore QoQ, while revenue rose to Rs 2,413 crore from Rs 2,359 crore.
In other strong earnings updates, Balaji Amines, Andhra Cements, ADF Foods, Black Rose, ZF Commercial, Permanent Magnets, BBTC, Hypersoft Technologies, Sagar Cement, Metropolis, Zaggle Prepaid, TVS Holding and Modi Naturals reported positive quarterly performance.
Order-related updates may also keep several counters active. PNC Infratech’s joint venture emerged as the L1 bidder for a Rs 572 crore UP bridge EPC project. NBCC India bagged two new construction projects worth Rs 131.02 crore. Refex Industries secured a new order worth Rs 36.50 crore from a Navratna Steel PSU, while Bajel Projects secured two major orders from Power Grid Corporation worth Rs 200 crore to Rs 300 crore each.
Lupin received U.S. FDA approval for Famotidine Injection USP, 20 mg/2 mL in single-dose vials. Zydus Lifesciences will be watched as its board is scheduled to meet on May 19 to consider a share buyback proposal. VA Tech Wabag signed a pact with PEAK Sustainability Ventures to develop its first Bio-CNG plant in Uttar Pradesh.
Among neutral updates, Bharti Airtel reported Q4 net profit of Rs 7,325 crore compared with Rs 6,631 crore QoQ, while revenue rose to Rs 55,383 crore from Rs 53,982 crore. Kaynes Tech reported Q4 net profit of Rs 91 crore against Rs 116 crore YoY, even as revenue rose to Rs 1,242 crore from Rs 984 crore. Redington, eClerx, Aeroflex, LIC Housing, DIC India, Signature Global and Expleo also posted quarterly updates.
Vodafone Idea will remain in focus as the company will announce its Q4 results on May 16, along with a board meeting to consider fundraising through equity and warrants. Easy Trip Planners approved a Rs 500 crore fundraising plan via rights issue of equity shares. Tata Capital allotted two tranches of non-convertible debentures worth Rs 505 crore and Rs 765 crore on a private placement basis.
On the negative side, Man Infraconstruction reported Q4 net profit of Rs 41 crore against Rs 97 crore YoY, while revenue declined to Rs 145 crore from Rs 293 crore. Crompton Greaves reported a Q4 net loss of Rs 534 crore against a profit of Rs 169 crore YoY, while revenue rose to Rs 2,283 crore from Rs 2,060 crore. DLF reported Q4 net profit of Rs 1,269 crore compared with Rs 1,282 crore YoY, while revenue declined to Rs 1,814 crore from Rs 3,128 crore.
Sugar stocks may also remain under pressure after India banned sugar exports until September 2026. Exports of raw, white and refined sugar have been banned with immediate effect.
Meanwhile, Sasken has been included in the short-term ASM framework, while Allied Blenders, Apollo Micro and Man Industries have been excluded from the ASM framework. NRB Bearings is ex-date today for an interim dividend of Rs 2.25, while Oberoi Realty will turn ex-date tomorrow for an interim dividend of Rs 2.
Overall, Thursday’s session is expected to remain stock-specific, with earnings, order wins, buyback updates, fundraising plans, regulatory changes and sector developments likely to guide individual stock movement.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Fingo is not liable for any losses arising from the use of this information.